article October 19, 2021
The Evolution of Site Selection
The site selection process became a central focus in clinical research amid COVID-19, but the truth is it has been evolving for decades. Javara CEO Jennifer Byrne was recently featured by Applied Clinical Trials, sharing insights into how Javara’s model is addressing systemic site selection challenges by making clinical trials available to patients as a care option.
Javara is the leading Integrated Research Organization (IRO) partnering with large healthcare organizations in local communities across the US to integrate clinical research into clinical care. Our access to broad diverse patient populations through their trusted physicians ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. Our team includes experienced clinical research leaders who have collectively led 10,000+ trials and engaged 200,000+ patients in clinical trials. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.
Javara Media Contact: